Life Science Company News

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »

Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annua

Read more ››
By: GlobeNewswire - 23 May 2024

NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 23 May 2024

FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical Onc

Read more ››
By: GlobeNewswire - 23 May 2024

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024

Read more ››
By: GlobeNewswire - 23 May 2024

Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

Read more ››
By: GlobeNewswire - 23 May 2024

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Premier Health Reports 2024 Second Quarter Results

Read more ››
By: GlobeNewswire - 23 May 2024

3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in San Diego, CA, June 3-6

Read more ››
By: GlobeNewswire - 23 May 2024

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

The Inner Circle Acknowledges, Keith D. Clancy, MD, MBA, FACS as a Pinnacle Lifetime Member

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Use of maternal race in prenatal screens for spina bifida is needed to ensure equitable medical care

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Activation Capital Introduces 'Frontier BioHealth' to Catalyze Life Science Startups

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Dr. Kent Reifschneider Scholarship for Pediatric Medicine Launches to Support Future Leaders in Pediatric Healthcare

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

The Bone Health & Osteoporosis Foundation and Sunsweet Growers Partner on Three-Part Podcast Series to Promote Importance of Women's Bone Health

Read more ››
By: PR Newswire Association LLC. - 23 May 2024
Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate